Aberdeen Group Portfolio holdings
AUM
$58.8B
1-Year Return
21.66%
This Quarter Return
+4.72%
1 Year Return
+21.66%
3 Year Return
+94.43%
5 Year Return
+162.75%
10 Year Return
–
AUM
$52.2B
AUM Growth
+$1.16B
(+2.3%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
30.01%
Holding
985
New
38
Increased
326
Reduced
528
Closed
39
Top Buys
| 1 |
Microsoft
MSFT
|
$281M |
| 2 |
Apple
AAPL
|
$264M |
| 3 |
Nu Holdings
NU
|
$128M |
| 4 |
CRH
CRH
|
$103M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$87.2M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$131M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$95.1M |
| 3 |
Exxon Mobil
XOM
|
$67M |
| 4 |
Amazon
AMZN
|
$59.5M |
| 5 |
Meta Platforms (Facebook)
META
|
$56.4M |
Sector Composition
| 1 | Technology | 31.84% |
| 2 | Healthcare | 16.47% |
| 3 | Financials | 10.07% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Live Nation Entertainment
LYV
$37.9B
| $3.79M | 0.01% |
40,409
-24,198
| -37% | -$2.27M |
|
677
New Fortress Energy
NFE
$672M
| $3.78M | 0.01% |
172,060
| – | – |
|
678
89bio
ETNB
$1.32B
| $3.77M | 0.01% |
470,387
| – | – |
|
679
Celanese
CE
$5.34B
| $3.77M | 0.01% |
27,922
-13,716
| -33% | -$1.85M |
|
680
Exact Sciences
EXAS
$10.2B
| $3.74M | 0.01% |
88,478
-21,855
| -20% | -$923K |
|
681
Adaptive Biotechnologies
ADPT
$1.96B
| $3.73M | 0.01% |
1,029,447
| – | – |
|
682
Structure Therapeutics
GPCR
$1.27B
| $3.66M | 0.01% |
+93,294
| New | +$3.66M |
|
683
Universal Health Services
UHS
$12.1B
| $3.57M | 0.01% |
19,289
-12,656
| -40% | -$2.34M |
|
684
Super Micro Computer
SMCI
$24B
| $3.53M | 0.01% |
43,110
+2,930
| +7% | +$240K |
|
|
CMBT
685
CMB.TECH NV
CMBT
$2.64B
| $3.53M | 0.01% |
+213,400
| New | +$3.53M |
|
686
Alliant Energy
LNT
$16.6B
| $3.48M | 0.01% |
68,378
-35,873
| -34% | -$1.83M |
|
687
Wynn Resorts
WYNN
$12.6B
| $3.43M | 0.01% |
38,277
-6,130
| -14% | -$549K |
|
688
Henry Schein
HSIC
$8.42B
| $3.42M | 0.01% |
53,326
-1,345
| -2% | -$86.2K |
|
689
VeriSign
VRSN
$26.2B
| $3.38M | 0.01% |
19,024
-20,975
| -52% | -$3.73M |
|
690
Phillips Edison & Co
PECO
$4.54B
| $3.38M | 0.01% |
103,307
+117
| +0.1% | +$3.83K |
|
691
BorgWarner
BWA
$9.53B
| $3.34M | 0.01% |
103,690
+3,350
| +3% | +$108K |
|
692
Xencor
XNCR
$610M
| $3.32M | 0.01% |
175,520
| – | – |
|
693
Eastman Chemical
EMN
$7.93B
| $3.32M | 0.01% |
33,895
-15,833
| -32% | -$1.55M |
|
694
Constellium
CSTM
$2.04B
| $3.3M | 0.01% |
+174,840
| New | +$3.3M |
|
695
Bio-Techne
TECH
$8.46B
| $3.26M | 0.01% |
45,550
-19,890
| -30% | -$1.43M |
|
696
Brown-Forman Class B
BF.B
$13.7B
| $3.25M | 0.01% |
75,355
-7,107
| -9% | -$307K |
|
697
Huntington Ingalls Industries
HII
$10.6B
| $3.24M | 0.01% |
13,163
-8,461
| -39% | -$2.08M |
|
698
Kenvue
KVUE
$35.7B
| $3.23M | 0.01% |
177,603
+12,956
| +8% | +$236K |
|
699
Pinnacle West Capital
PNW
$10.6B
| $3.21M | 0.01% |
42,063
-3,569
| -8% | -$273K |
|
700
Axsome Therapeutics
AXSM
$6.25B
| $3.19M | 0.01% |
+39,675
| New | +$3.19M |
|